Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Hyperthermia × tislelizumab × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 8 Esophageal Squamous Cell Carcinoma 6 Carcinoma, Non-Small-Cell Lung 6 Stomach Neoplasms 4 Neoplasm Metastasis 4 Head and Neck Neoplasms 4 Recurrence 3 Lung Neoplasms 3 Colorectal Neoplasms 3 Advanced Solid Tumors 3 Advanced Solid Tumor 3 Squamous Cell Carcinoma of Head and Neck 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Ovarian Neoplasms 1 Neoplasms 1 Nasopharyngeal Neoplasms 1 NSCLC 1 Multiple Pulmonary Nodules 1 Mid-low Rectal Cancer 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1

Interventions

Melphalan 3 Diathermy 2 Cytoreduction Surgical Procedures 2 Conization 2 tislelizumab 1 spartalizumab 1 sodium thiosulfate 1 Radiotherapy 1 Leucovorin 1 Laparotomy 1 Immune Checkpoint Inhibitors 1 Fluorouracil 1 Floxuridine 1 Drug Therapy 1 Cryotherapy 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06022692 2023-09-05

HEAIS001

Zhejiang Hospital

Phase 1/2 Completed

Gastrointestinal

Hyperthermia, Digestive System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡